Skip to content
WeighLab
Menu
Ranked #346 · Grade C

Midi Health review

Midi Health is a nationwide 50-state menopause and perimenopause telehealth platform.

Visit Midi Health Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
Not disclosed
Tirzepatide
Not disclosed
Coverage
All 50 states
Brand-name
Compounded only

The Index scorecard

Midi Health scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month45/100
Price Transparency20/100
Nationwide Access86/100
Formulation Options40/100
Clinical Oversight77/100
Contract Flexibility55/100

Where the value is

  • Available in all 50 states
  • Accepts commercial insurance — a differentiator vs cash-pay-only GLP-1 telehealth
  • Menopause + metabolic-health focus suits women where GLP-1 efficacy and weight regulation overlap most
  • Transparent self-pay visit fees ($250 initial, $150 follow-up); GLP-1 can also be billed through commercial insurance (copay + deductible)

The tradeoffs

  • Does not accept Medicare, Medicaid, or Medi-Cal
  • GLP-1 is prescribed at clinician discretion within a menopause plan, not guaranteed at intake
  • Menopause-focused — not the right fit for men or younger women whose main goal is weight loss

The bottom line

Best for: Cost-first shoppers who want menopause-focused care with GLP-1 as a metabolic adjunct. Midi Health is a nationwide 50-state menopause and perimenopause telehealth platform.

Ranked #346 of 492 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 491 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Midi Health.

The 18 programs nearest this one

Pricing, states and verification reflect Midi Health's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Midi Health's site. Not medical advice; see our disclosure.

← Back to the value leaderboard